Ethnicity and persistent symptom burden in breast cancer survivors
- PMID: 19859813
- PMCID: PMC4852143
- DOI: 10.1007/s11764-009-0100-7
Ethnicity and persistent symptom burden in breast cancer survivors
Abstract
Introduction: Relatively few studies of breast cancer survivors have included nonwhite women or women who do not speak English.
Methods: We administered a survey to patients who were >or=3 months post-completion of their adjuvant treatment for stage 0-III breast cancer at Columbia University Medical Center in order to assess the prevalence of 16 physical and emotional symptoms and identify sociodemographic factors associated with these symptoms. Univariate analysis, factor analysis, ANOVA, and multiple linear regression analysis were performed.
Results: Of 139 patients surveyed, 58 were white, 63 Hispanic, and 18 black. The symptom most commonly reported was fatigue(76%), and the most common severe symptom was muscle aches(40%). Most patients(70%) complained of >or=6 symptoms. Hispanic women were more likely to report >10 symptoms (p < 0.05). Factor analysis reduced the 16 symptoms to 4 underlying symptom clusters that we categorized as 'depression', 'chemotherapy', 'hormone', and 'pain'-related. In the multiple linear regression models, Hispanic women were more likely to report chemotherapy-related symptoms (p < 0.05) and pain-related symptoms (p < 0.05). Unemployed women were more likely to report chemotherapy-related symptoms (p < 0.05). Women <45 years old were less likely to report chemotherapy (p < 0.05) and pain-related symptoms (p < 0.05).
Conclusions: The majority of women in this study, particularly those who were Hispanic, elderly, or unemployed, experienced persistent symptoms, most commonly fatigue and muscle aches.
Implications for cancer survivors: Because Hispanic, elderly, or unemployed women experience greater symptom burden, efforts should made to address their unique needs.
Figures
References
-
- American Cancer Society. Cancer Reference Information. 2009 Available at: http://www.cancer.org/docroot/CRI/content/CRI_2_2_1X_How_many_people_get....
-
- Smith K, Avis NE, Assmann SF. Distinguishing between quality of life and health status in quality of life research: a meta-analysis. Qual Life Res. 1999;8:447–59. - PubMed
-
- Ganz PA, Rowland J, Meyerowitz B. Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. Recent Results Cancer Res. 1998;152:396–411. - PubMed
-
- Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol. 1998;16:1380–7. - PubMed
-
- Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B. Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol. 1998;16:487–94. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical